This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Importance Of Evidence-Based Medicine Presented In New Issue Brief Available From Elsevier

PHILADELPHIA, April 25, 2013 /PRNewswire/ --

Report identifies potential impact of evidence-based medicine in meeting today's healthcare challenges

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of the first in a series of issue briefs on evidence-based medicine (EBM). The issue brief - "Building a Business Case for Evidence-Based Medicine" - reveals the urgent need for EBM, as identified in a roundtable discussion of healthcare industry thought leaders at the CMIO Leadership Forum: Transforming Healthcare Through Evidence-based Medicine , last fall in Chicago.

The roundtable discussion, which featured five physicians representing hospital and healthcare technology CMIOs, research directors and clinical professors, was convened by the developers of ClinicalKey, Elsevier's clinical insight engine designed to help physicians quickly locate accurate answers to their clinical questions. The issue brief, based on the roundtable, emphasizes the need for a business case for EBM as a central necessity to enhancing the American healthcare system. According to findings highlighted within the brief, making the business case for EBM will not be attributed to a single event or destination, but will become more of a process or journey.

"By relying on fast, comprehensive, point-of-care clinical reference tools, clinicians will be better able to pursue the 'shared practice' approach so vital to the patient-centered medical home and accountable care," said David Goldmann, M.D., Vice President and Chief Medical Quality Assurance Officer at Elsevier. "EBM solutions have the potential to accelerate and improve clinical decision making and patient outcomes."

EBM is a long-term, problem-based learning process that involves:

  • Conversion of information needs into focused questions
  • Identification of the best evidence for answering a question
  • Review of evidence for validity and clinical usefulness
  • Application of results to clinical practice
  • Evaluation of how the evidence performs in clinical applications

Identified within this brief are opportunities and strategies that will assist the healthcare system through the EMB journey such as:

  • The U.S. faces a serious shortage of primary care clinicians with an estimated increase in the advanced practice clinician workforce by 15 percent within the year; solutions - many involving technologies like clinician insight engines - are already in sight for many practices.
  • EBM can go a long way in reducing healthcare's failure to implement preventive and patient safety best practices, which typically result in injuries, negative patient outcomes and runaway costs. It can also minimize the burden of overtreatment, where physicians' habits and preferences sometimes trump medical evidence.
  • In an environment where operating costs continue to collide with declining reimbursement, HCOs struggle to maintain revenue, manage overhead and ensure quality, safety and efficiency. EBM will play a critical role in helping healthcare leaders make informed, disciplined choices on a broad array of challenges-from physician integration, hospital consolidation, strategic alignments and new reimbursement models, to technology optimization, risk mitigation, changing populations, and patient engagement.

Although EBM continues to evolve, it has already proven its capacity to influence top-line healthcare issues. An analysis of EBM's potential impact on healthcare's most pressing challenges, including clinician shortages, waste, accountable care and patient engagement is also identified as an imperative need within the healthcare system and further elaborated on in the issue brief.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs